Search

West Pharmaceutical Services Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

340.33 0.48

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

340.01

Max

342.55

Pagrindiniai rodikliai

By Trading Economics

Pajamos

15M

154M

Pardavimai

27M

872M

P/E

Sektoriaus vid.

42.414

64.641

Pelnas, tenkantis vienai akcijai

2.37

Dividendų pajamingumas

0.27

Pelno marža

17.654

Darbuotojai

10,800

EBITDA

-39M

179M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+18.12% upside

Dividendai

By Acuity

Dividendų pajamingumas

Sektoriaus vid.

0.27%

2.31%

Kitas uždarbis

2026-10-22

Kitas dividendų mokėjimo data

2026-08-05

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-1.6B

23B

Ankstesnė atidarymo kaina

339.85

Ankstesnė uždarymo kaina

340.33

Naujienos nuotaikos

By Acuity

50%

50%

155 / 340 reitingas Healthcare

West Pharmaceutical Services Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-07-31 23:01; UTC

News

West Pharmaceutical Services shares are lower in after-market trading despite strong Q2 results and raised full-year guidance, reflecting mixed market sentiment.

2026-07-29 19:44; UTC

Macro Event

West Pharmaceutical Services is slightly lower amid broader market declines following the Federal Reserve's decision to keep interest rates steady.

2026-07-28 23:31; UTC

West Pharmaceutical Services shares declined in after-market trading, tracking broader market losses amid rising competition in the semiconductor sector.

2026-07-27 19:41; UTC

News

Evercore ISI raised its price target on West Pharmaceutical Services to $425, contributing to positive sentiment as shares trade higher since Friday's close.

2026-07-24 22:01; UTC

West Pharmaceutical Services Inc shares are lower in after-market hours, continuing a trend of recent declines despite earlier volatility during the session.

2026-07-22 22:51; UTC

West Pharmaceutical Services Inc shares are trading higher in after-market hours, supported by strong performance relative to their 20-day moving average and one-month range.

2026-07-21 19:46; UTC

News

West Pharmaceutical Services has secured long-term agreements with Daikyo Seiko, enhancing its global reach. Shares are trading higher amid positive market momentum.

2026-07-20 19:16; UTC

West Pharmaceutical Services is lower today, influenced by a notable decline in the Life Sciences Tools & Services sub-sector. No specific news was identified.

Akcijų palyginimas

Kainos pokytis

West Pharmaceutical Services Inc Prognozė

Kainos tikslas

By TipRanks

18.12% į viršų

12 mėnesių prognozė

Vidutinis 402.75 USD  18.12%

Aukščiausias 447 USD

Žemiausias 365 USD

Remiantis 9 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines West Pharmaceutical Services Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

9 ratings

8

Pirkti

1

Laikyti

0

Parduoti

Rinkos nuotaikos

By Acuity

155 / 340 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Aukščiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
help-icon Live chat